ArticleInternational journal of women's health2025
Construction of a Nomogram Prediction Model for Individualized Prediction of Cervical Cancer Risk: A Retrospective Study.
Article in International journal of women's health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Development and Validation of a Machine Learning-Based Prediction Model for Illness Uncertainty in Patients with Malignant Tumors.Healthcare (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To construct and validate a nomogram prediction model for the risk of cervical cancer. Methods: From May 2021 to September 2023, 1234 female patients who underwent cervical cancer examinations were included in the training set and divided into a cervical cancer group (97 cases) and a non-cervical cancer group (1137 cases). In addition, 528 women who underwent cervical cancer screening between October 2023 and October 2024 were included as the validation set. Multivariate logistic regression analysis was used to identify independent risk factors. R software was used to establish a nomogram prediction model. Moreover, ROC curve analysis, the Hosmer-Lemeshow (H-L) test, calibration plots, and decision curve analysis were used to evaluate the predictive performance of the model. Results: There was a statistically significant difference in the positivity of human papillomavirus (HPV) between the training set and the validation set (P<0.05). Education level of junior high school or below, menarche age ≤14 years, first sexual intercourse age ≤ 20 years, number of sexual partners > 2, long-term use of hormonal contraceptives, number of deliveries > 2, HPV positivity, cervicitis, and systemic lupus erythematosus were independent risk factors for cervical cancer (P<0.05). The AUCs of ROC curve for internal and external validation were 0.867 and 0.850, respectively. H-L test showed Conclusion: The Nomogram model based on nine identified factors provides a reliable tool to assist in the early detection and risk assessment of cervical cancer, which may help identify high-risk populations and guide targeted screening strategies in clinical practice.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.